"Community Cancer Center North, located on the Community North campus, is filled with hope, collaboration and easy navigation. Patients find world-class care from a multidisciplinary team of certified medical experts, utilizing state-of-the-art technology and treatment protocols. The new cancer treatment facility is designed as a model for integrated healthcare to meet patients' personal needs. Inside, the center offers spaces devoted to support groups, physical therapy, art and music therapy, tai chi, massage, exercise and much more. Our cancer team is deep with expertise. All physicians are board-certified medical oncologists/hematologists and radiation oncologists, many of whom are also MD Anderson Cancer Network certified physicians."

During the past decade, Community Cancer Center North conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 28 clinical trials were completed, i.e. on average, 73.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Cancer Center North" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "Radiation Therapy Oncology Group" with 12 trials sponsored, "Hoosier Cancer Research Network" with 10 trials sponsored, "Nasser Hanna, M.D." with 5 trials sponsored and "SWOG Cancer Research Network" with 5 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Cancer Center North" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Walther Cancer Institute" with 10 trials as a collaborator, "Hoosier Cancer Research Network" with 7 trials as a collaborator and "Canadian Cancer Trials Group" with 5 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Community Cancer Center North" are "Breast Cancer" (11 trials), "Lung Cancer" (7 trials), "Head and Neck Cancer" (4 trials), "Recurrent Breast Carcinoma" (4 trials) and "Bladder Cancer" (3 trials). Many other conditions were trialed in "Community Cancer Center North" in a lesser frequency.

Most popular intervention types in "Community Cancer Center North" are "Drug" (61 trials), "Other" (34 trials), "Radiation" (32 trials), "Biological" (23 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Laboratory Biomarker Analysis" (12 trials), "Pembrolizumab" (9 trials), "Biospecimen Collection" (8 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Community Cancer Center North" are 63 trials for "All" genders, 17 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Community Cancer Center North". undefined are not yet recruiting, 15 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Community Cancer Center North, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Community Cancer Center North, 7 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".